Saturday , May 28 2022

Breast cancer drugs. 2x Survival Rate – Fresh



[ad_1]

https://www.prachachat.net/wp-content/uploads/2018/11/dlf06151161p1.jpg

Breast cancer is the most common type of cancer among Thai women and women around the world. Currently, the number of people with this disease increases every year. In the early stages of breast cancer, there are often no signs or symptoms. The patient is aware that cancer has spread to third to fourth. Treatment of breast cancer Previous surgery, chemotherapy, anti-hormonal treatment, but there is another alternative treatment over the last 1 year. After the United States, Pfizer. Innovative medicine for breast cancer in spreading and spreading. In Thailand, this drug was approved by the drug. In the past year, Pfizer Thailand donated this drug to Thailand's Oncology Association last year. For the treatment of 50 patients with metastatic breast cancer, Prof. Dr. Viroj Sriroonpong, Head of Medical Center for Excellence Full Cancer King Memorial Hospital Chulalongkorn The president of the Thai Oncology Association said the drug is an anticancer drug that inhibits CDK 4/6, which is approved by the Food and Drug Administration as the first drug. First line in patients with advanced or metastatic breast cancer. ER + / HER 2 menopause. Dr. Viroj said that the drug has two formulas that will be used differently. The first formulation is used by patients who have never received hormonal treatment. […]


Breast cancer drugs. The 2-fold increase in survival rate first appeared on nations.

[ad_2]
Source link